An ME/CFS Scientific Advisory Board With THREE Nobel Laureates On It


Founder of Health Rising and Phoenix Rising
Staff member
Are we moving up or what?

Another Nobel laureate Paul Berg - has been added. That's almost 30% Nobel Laureates!


Ronald W. Davis, PhD, Director: Dr. Davis’s history of interdisciplinary work, technology development, and attacking previously unsolvable biological problems (both in genetics and traumatology), makes him the ideal scientist to lead a collaborative consortium to solve the mystery of ME/CFS.

Dr. Davis is Professor of Biochemistry and Genetics at Stanford University School of Medicine and he is the Director of the Stanford Genome Technology Center. Dr. Davis holds a PhD in Chemistry from Caltech. He is a member of the National Academy of Sciences.


Mario Capecchi, PhD: Dr. Capecchi is an expert on human genetics, with a focus on the interaction of immune cells in the brain. His current research involves investigating the molecular genetic causes underlying human disorders involving the immune system and the brain. His expertise and insights in this area will be essential in understanding ME/CFS.

Dr. Capechhi is a Nobel Laureate in Physiology or Medicine. He is Distinguished Professor of Human Genetics at University of Utah School of Medicine. Dr. Capecchi holds a PhD in Biophysics from Harvard University. He is a member of the National Academy of Sciences.


Mark M. Davis, PhD: As a world famous immunologist, Dr. Davis’ focus is to develop a broad understanding of the human immune system to gain more coordinated information about what a healthy immune system looks like. The immune system is clearly involved in ME/CFS and Dr. Davis will be invaluable on the Advisory Board.

Dr. Davis is Professor of Microbiology and Immunology at Stanford University School of Medicine and Director of the Stanford Institute for Immunity, Transplantation and Infection. Dr. Davis holds a PhD in Molecular Biology from Caltech. He is a member of the National Academy of Sciences.


H. Craig Heller, PhD: Dr. Heller has a wide breadth of knowledge of biology. He conducts extensive research in exercise physiology, examining fatigue in athletes. Dr. Heller has developed an instrument that allows increased exercise without fatigue. Having someone who understands fatigue and the normal response to exercise is essential for understanding how it goes wrong in ME/CFS.

Dr. Heller is Professor of Biology at Stanford University. He holds a PhD in Biology from Yale University and is a physiologist and biologist at Stanford.


Andreas M. Kogelnik, MD, PhD: As an infectious disease specialist, Dr. Kogelnik is centrally involved with the bioinformatics and genomic revolution in medicine and is committed to the study of and treatment of ME/CFS and other chronic illnesses. His approach to treatment is based upon scientific evidence and he has led the charge on collecting large scale data and samples for ME/CFS research.

Dr. Kogelnik is a physician-scientist and Founder and Director of the Open Medicine Institute. He holds an MD from Emory University and a PhD in Bioengineering from Georgia Tech. He completed his residency in Internal Medicine and a Fellowship in Infectious Diseases at Stanford.


Baldomero M. Olivera, PhD: Through his studies in neurobiology and cone snails Dr. Olivera has been able to develop a number of pain drugs, one of which is a thousand times more effective than morphine. Dr. Olivera is an expert on conotoxins that can modulate nerve function. He believes the future of neuroscience depends on collaboration across disciplines. Dr. Olivera will add to the Advisory Board his expertise in neurobiology and developing drugs for intervening in neurological processes, as well as his extraordinary creativity and thoughtful approach to scientific problems.

Dr. Olivera is a Distinguished Professor of Biology at the University of Utah and is a lead scientist in the research of cone snail toxins. He holds a PhD in biophysical chemistry from Caltech. He is a member of the National Academy of Sciences.


Ronald G. Tompkins, MD, ScD: Dr. Tompkins has a very broad knowledge of trauma and metabolism. He ran the large NIH-funded Glue Grant for Inflammation and Host Response to injury in Humans, a large-scale collaborative research program that generated and analyzed likely the largest data set ever collected on humans. There seems to be a relationship between trauma and ME/CFS, possibly being triggered by or putting the body into a constant state of trauma. Dr. Tompkins is skilled at getting a diverse group of scientists and doctors to work together and collaborate. Having him on the Advisory Board is instrumental to successfully managing such a big project.

Dr. Tompkins is a Professor of Surgery at the Harvard Medical School. He is also Chief of Trauma, Burns and Surgical Critical Care Service at the Massachusetts General Hospital and Chief of Staff at the Shriners Hospitals for Children in Boston. Dr. Tompkins is a leading trauma and burn physician and trauma specialist at the Massachusetts General Hospital.


James D. Watson, PhD: Dr. Watson served as Director of the Human Genome Project from 1990 till 1992. Under his leadership the project was highly successful and came in under budget and ahead of schedule. Dr. Watson has written three widely used textbooks. He is a leader in complex scientific problem solving, and has a track record of successful fund raising in both public and private sectors. Dr. Watson has a great ability for seeing the big picture and has the knowledge, connections, and experience to help set up an effective project.

Dr. Watson is Nobel Laureate in Physiology or Medicine. He is Chancellor of Cold Spring Harbor Laboratories. Dr. Watson holds a PhD in Zoology from Indiana University. He is a member of the National Academy of Sciences.


Wenzhong Xiao, PhD: As a world expert in computational genomics, Dr Xiao develops bioinformatic and statistical tools for use in understanding human diseases, especially in studies of immuno-metabolic response. He focuses on integrative analysis and interpretation of multi-dimensional molecular, cellular and clinical data of many types of patients, including those with ME/CFS. Dr. Xiao’s expertise will be essential for the interpretation of the massive data sets that will be collected in this project.

Dr. Xiao is Assistant Professor of Bioinformatics at Harvard Medical School, and Director of the Inflammation & Metabolism Computational Center at Massachusetts General Hospital. He also leads a Computational Genomics Group at Stanford Genome Technology Center. He holds a PhD in Chemistry and Structural Biology from University of California at Berkeley, and a Masters Degree in Statistics.



Well-Known Member
I wonder if the Doctor who finds the cure for ME/CFS will receive a Nobel or just a pat on the back "there you go champ, nice job".


Founder of Health Rising and Phoenix Rising
Staff member
He/she will deserve a Nobel for all the bs he/she will have to go through...


Well-Known Member
This gives me hope that there are actually researchers seriously studying ME/CFS and looking for answers. :)


Founder of Health Rising and Phoenix Rising
Staff member
Serious researchers - studying ME/CFS - if they can get the money!
This gives me hope that there are actually researchers seriously studying ME/CFS and looking for answers. :)

Get Our Free ME/CFS and FM Blog!

Forum Tips

Support Our Work



Shopping on For HR

Latest Resources